BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2657115)

  • 1. Immunoresponse of tissue infiltrating lymphocytes in bladder tumors.
    Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
    J Urol; 1989 Jun; 141(6):1467-70. PubMed ID: 2657115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of tissue-infiltrating lymphocytes in bladder tumors.
    Tsujihashi H; Uejima S; Akiyama T; Kurita T
    Urol Int; 1989; 44(1):5-9. PubMed ID: 2665263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.
    Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
    J Urol; 1988 Oct; 140(4):890-4. PubMed ID: 3262173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical characterization of lymphocytes and histiocytes in bladder cancers in terms of local immune responses].
    Hanai S; Shimosato Y; Watanabe S; Sato Y; Kishi K; Kakizoe T; Matsumoto K
    Gan No Rinsho; 1985 Jun; 31(7):839-46. PubMed ID: 2411967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y; Yoshida O
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lymphocyte subpopulations in patients with bladder cancer: a study with monoclonal antibodies.
    Morita T; Yonese Y; Minato N
    Hinyokika Kiyo; 1987 Jun; 33(6):838-43. PubMed ID: 3499769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.
    Reyes E; Carballido J; Prieto A; Molto L; Manzano L; Alvarez-Mon M
    Eur Urol; 1997; 31(4):472-7. PubMed ID: 9187910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of immune surveillance for bladder tumor. II. Immunoresponse of tissue infiltrating lymphocytes following immunomodulator injection in bladder tumors].
    Tsujihashi H; Matsude H; Akiyama T; Kurita T; Uejima S
    Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):115-21. PubMed ID: 3260977
    [No Abstract]   [Full Text] [Related]  

  • 9. [The study of infiltrating lymphocytes in the tissues of bladder carcinoma].
    Fujimoto Y; Hasegawa Y; Kato N; Sakai S; Kuriyama M; Kawada Y; Nishiura T; Takeuchi T; Isogai K
    Hinyokika Kiyo; 1983 Sep; 29(9):1037-45. PubMed ID: 6610297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
    Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomas.
    Cresswell J; Robertson H; Neal DE; Griffiths TR; Kirby JA
    Clin Exp Immunol; 2001 Dec; 126(3):397-402. PubMed ID: 11737053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
    Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
    J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lewis a antigen in transitional cell tumors of the urinary bladder.
    Juhl BR; Hartzen SH; Hainau B
    Cancer; 1986 Jul; 58(2):222-8. PubMed ID: 3521828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
    Jacobsen F
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):175-80. PubMed ID: 7315355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Degree of lymphocytic infiltration of the epithelium in bladder tumors].
    Sapritskiĭ AV; Panchenko KI
    Vopr Onkol; 1983; 29(7):66-71. PubMed ID: 6880136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.
    Krpina K; Babarović E; Španjol J; Đorđević G; Maurer T; Jonjić N
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):248-52. PubMed ID: 26659909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte response to transitional cell carcinoma: peripheral cytotoxicity and local tumor infiltration.
    Jones LW; O'Toole C
    J Urol; 1977 Dec; 118(6):974-7. PubMed ID: 926279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma.
    Kagawa S; Ogura K; Kurokawa K; Uyama K
    J Urol; 1979 Oct; 122(4):467-70. PubMed ID: 480487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.